We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.66%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$14.8B
AUM Growth
+$2.81B
(+24%)
Cap. Flow
+$1.65B
Cap. Flow
% of AUM
11.18%
Top 10 Holdings %
Top 10 Hldgs %
32.19%
Holding
1,185
New
65
Increased
729
Reduced
346
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$323M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$107M |
| 3 |
Texas Instruments
TXN
|
+$85.9M |
| 4 |
Tesla
TSLA
|
+$67.3M |
| 5 |
Intel
INTC
|
+$65.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$45M |
| 2 |
NVIDIA
NVDA
|
+$36.4M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$26.7M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
+$21.1M |
| 5 |
JPMorgan Chase
JPM
|
+$19.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.08% |
| 2 | Financials | 11.46% |
| 3 | Healthcare | 8.37% |
| 4 | Energy | 5.47% |
| 5 | Consumer Discretionary | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Deere & Co
DE
$163B
| $7.29M | 0.05% |
17,654
+802
| +5% | +$332K |
|
277
Ionis Pharmaceuticals
IONS
$9.06B
| $7.29M | 0.05% |
203,887
-15,092
| -7% | -$567K |
|
|
BPMC
278
DELISTED
Blueprint Medicines
BPMC
| $7.28M | 0.05% |
161,890
-8,792
| -5% | -$396K |
|
279
TG Therapeutics
TGTX
$7.07B
| $7.26M | 0.05% |
483,035
-268,744
| -36% | -$4.08M |
|
280
Novavax
NVAX
$1.22B
| $7.23M | 0.05% |
1,043,277
+554,753
| +114% | +$5.1M |
|
281
Kraft Heinz
KHC
$31.3B
| $7.22M | 0.05% |
186,623
+30,627
| +20% | +$1.21M |
|
|
APLS
282
DELISTED
Apellis Pharmaceuticals
APLS
| $7.22M | 0.05% |
109,398
-54,706
| -33% | -$3.16M |
|
283
Constellation Energy
CEG
$97.7B
| $7.21M | 0.05% |
91,869
+20,137
| +28% | +$1.63M |
|
284
Zoetis
ZTS
$32.3B
| $7.21M | 0.05% |
43,325
+1,285
| +3% | +$211K |
|
285
Alkermes
ALKS
$8.31B
| $7.21M | 0.05% |
255,668
-72,350
| -22% | -$1.97M |
|
286
CoStar Group
CSGP
$12.2B
| $7.19M | 0.05% |
104,386
+18,166
| +21% | +$1.34M |
|
287
Neurocrine Biosciences
NBIX
$16.7B
| $7.19M | 0.05% |
70,988
+2,334
| +3% | +$243K |
|
288
CRISPR Therapeutics
CRSP
$4.88B
| $7.12M | 0.05% |
157,446
-7,206
| -4% | -$350K |
|
289
Revolution Medicines
RVMD
$38.8B
| $7.1M | 0.05% |
327,586
+90,268
| +38% | +$2.22M |
|
290
First Horizon
FHN
$12.2B
| $7.09M | 0.05% |
398,686
+314,011
| +371% | +$6.98M |
|
291
Keurig Dr Pepper
KDP
$42.1B
| $7.09M | 0.05% |
200,857
+29,989
| +18% | +$1.05M |
|
292
Ultragenyx Pharmaceutical
RARE
$2.46B
| $7.04M | 0.05% |
175,575
-22,725
| -11% | -$975K |
|
293
Equinix
EQIX
$102B
| $7.01M | 0.05% |
9,721
+1,232
| +15% | +$867K |
|
294
Vir Biotechnology
VIR
$1.5B
| $7M | 0.05% |
300,846
-7,581
| -2% | -$194K |
|
295
Natera
NTRA
$38.7B
| $6.98M | 0.05% |
125,748
-85,702
| -41% | -$4.11M |
|
|
SAGE
296
DELISTED
Sage Therapeutics
SAGE
| $6.95M | 0.05% |
165,731
+1,874
| +1% | +$80.6K |
|
|
KRTX
297
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $6.89M | 0.05% |
37,955
-3,097
| -8% | -$592K |
|
298
Prothena Corp
PRTA
$436M
| $6.87M | 0.05% |
141,689
+3,336
| +2% | +$176K |
|
299
BioCryst Pharmaceuticals
BCRX
$2.24B
| $6.84M | 0.05% |
820,521
+52,448
| +7% | +$505K |
|
300
Cigna
CI
$74.5B
| $6.83M | 0.05% |
26,739
+479
| +2% | +$140K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Rafferty Asset Management held 1,185 positions worth $14.8B, up 24% from $11.9B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Rafferty Asset Management deployed $1.65B of net new capital in Q1 2023, opening 65 new positions and adding to 729 existing holdings. Its largest new stake was Flagstar Bank National Association: 362,459 shares worth $9.83M.
By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $45M trimmed.
- Rafferty Asset Management's largest Q1 2023 buy was Flagstar Bank National Association: 362,459 shares worth $9.83M.
- Rafferty Asset Management added most to iShares 20+ Year Treasury Bond ETF in Q1 2023, an estimated $323M increase.
- Rafferty Asset Management's biggest Q1 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $45M.
- Rafferty Asset Management fully exited SVB Financial Group in Q1 2023, selling an estimated $7.88M.
- Rafferty Asset Management's ten largest holdings make up 32% of its $14.8B portfolio in Q1 2023.
- Rafferty Asset Management opened 65 new positions and closed 45 in Q1 2023.
- Rafferty Asset Management's portfolio value rose 24% quarter-over-quarter to $14.8B.
Based on Rafferty Asset Management's 13F filing for Q1 2023, filed 11 May 2023.